SGLT2 Inhibitors and Their Antiarrhythmic Properties.

Int J Mol Sci · 2022 · PMC8835896 · PMID 35163599

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This highly significant finding was also consistent after excluding reports on used antiarrhythmic drugs, renal disease and/or other cardiovascular disease, indicating a robust antiarrhythmic effect [ 94 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.